EGFR mAb425 for diagnosing and treating EGF-R+ tumors
![](https://www.wistar.org/wp-admin/admin-ajax.php?action=kernel&p=image&src=%7B%22file%22%3A%22wp-content%2Fuploads%2F2023%2F09%2FClinical-Studies.png%22%2C%22thumbnail%22%3A%222500%2C%2C%22%7D&hash=f8d99e41)
Lead Wistar Inventor
Meenhard Herlyn, DVM, D.Sc.
Inquiries
Collaboration Opportunity
The mAb 425 hybridoma has been exclusively optioned to a strategic collaborator.